Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Moleculin Biotech Inc | MBRX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
5.04 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 4.28 - 15.75 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 5.04 | USD |
Moleculin Biotech Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
168.4M | 33.41M | - | 0 | -29.77M | -0.89 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Moleculin Biotech News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MBRX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 5.00 | 5.47 | 4.79 | 5.05 | 20,040 | 0.04 | 0.80% |
1 Month | 5.09 | 5.91 | 4.28 | 4.77 | 21,538 | -0.05 | -0.98% |
3 Months | 8.022 | 10.35 | 4.28 | 7.03 | 105,112 | -2.98 | -37.17% |
6 Months | 8.5485 | 15.75 | 4.28 | 8.62 | 145,992 | -3.51 | -41.04% |
1 Year | 12.075 | 15.75 | 4.28 | 8.79 | 151,097 | -7.04 | -58.26% |
3 Years | 50.0775 | 59.85 | 4.28 | 24.06 | 159,837 | -45.04 | -89.94% |
5 Years | 21.45 | 131.70 | 4.28 | 26.82 | 947,972 | -16.41 | -76.50% |
Moleculin Biotech Description
Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member. |